Clinical Trials on NAFLD/MASLD in Sweden
Total 8 results
-
Karolinska University HospitalCompleted
-
Helsinki University Central HospitalGöteborg University; Sahlgrenska University Hospital, SwedenCompleted
-
Uppsala UniversityCompletedDiabetes Mellitus, Type 2 | PreDiabetes | NAFLDSweden
-
AstraZenecaCompletedHypertriglyceridemia | Non-alcoholic Fatty Liver Disease (NAFLDSweden
-
Ali AminianNot yet recruitingObesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
-
University of OxfordAssistance Publique - Hôpitaux de Paris; University of Nottingham; Novartis; Pf... and other collaboratorsActive, not recruitingNAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NASH | Steatosis of LiverUnited Kingdom, Finland, Sweden, Spain, Greece, United States, Switzerland, Italy, France, Germany
-
Newcastle UniversityAssistance Publique - Hôpitaux de Paris; Medical University of Vienna; University... and other collaboratorsRecruitingCardiovascular Diseases | Hypertension | Obesity | Hepatocellular Carcinoma | Type 2 Diabetes | NAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Dyslipidaemia | NASH | Steatosis of Liver | Other Associated ComorbiditiesNetherlands, Germany, United Kingdom, Finland, Belgium, Greece, Italy, Sweden, Portugal, Spain, France, Switzerland